The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01
Abstract
Purpose: To report mature results of a randomized trial that compared extended-field radiotherapy (EFRT) versus pelvic radiotherapy with concomitant fluorouracil and cisplatin (CTRT) in women with locoregionally advanced carcinomas of the uterine cervix. Patients and Methods: Four hundred three women with cervical cancer were randomly assigned to receive either EFRT or CTRT. Patients were eligible if they had stage IIB to IVA disease, stage IB to IIA disease with a tumor diameter ≥ 5 cm, or positive pelvic lymph nodes. Patients were stratified by stage and by method of lymph node evaluation. Results: The median follow-up time for 228 surviving patients was 6.6 years. The overall survival rate for patients treated with CTRT was significantly greater than that for patients treated with EFRT (67% v 41% at 8 years; P < .0001). There was an overall reduction in the risk of disease recurrence of 51% (95% CI, 36% to 66%) for patients who received CTRT. Patients with stage IB to IIB disease who received CTRT had better overall and disease-free survival than those treated with EFRT (P < .0001); 116 patients with stage III to IVA disease had better disease-free survival (P = .05) and a trend toward better overall survival (P = .07) if they were randomly assigned to CTRT. The rate of serious late complications of treatment was similar for the two treatment arms. Conclusion: Mature analysis confirms that the addition of fluorouracil and cisplatin to radiotherapy significantly improved the survival rate of women with locally advanced cervical cancer without increasing the rate of late treatment-related side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke-Pearson, D. L., & Insalaco, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401502 · Cited by 2,658
Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M., & Mutch, D. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401501 · Cited by 2,299
Self-citationPeters, W. A., Liu, P. Y., Barrett, R. J., Stock, R. J., Monk, B. J., Berek, J. S., Souhami, L., Grigsby, P., Gordon, W., & Alberts, D. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1606 · Cited by 2,284
Self-citationKeys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L., Walker, J. L., & Gersell, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401503 · Cited by 1,923
Whitney, C. W., Sause, W., Bundy, B. N., Malfetano, J. H., Hannigan, E. V., Fowler, Jr., Clarke-Pearson, D. L., & Liao, S.-Y. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1339 · Cited by 1,524
Cited by
Cervical cancer: A global health crisis
Small, W., Bacon, M. A., Bajaj, A., Chuang, L. T., Fisher, B. J., Harkenrider, M. M., Jhingran, A., Kitchener, H. C., Mileshkin, L. R., Viswanathan, A. N., et al. (2017) · Cancer · doi:10.1002/cncr.30667 · Cited by 1,168
(2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4368 · Cited by 971
Repopulation of cancer cells during therapy: an important cause of treatment failure
Kim, J. J., & Tannock, I. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1650 · Cited by 686
Dueñas-González, A., Zarbá, J. J., Patel, F., Alcedo, J. C., Beslija, S., Casanova, L., Pattaranutaporn, P., Hameed, S., Blair, J. M., Barraclough, H., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9663 · Cited by 484
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix
Green, J. A., Kirwan, J. J., Tierney, J., Vale, C. L., Symonds, P. R., Fresco, L. L., Williams, C., & Collingwood, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002225.pub2 · Cited by 415
Lorusso, D., Xiang, Y., Hasegawa, K., Scambia, G., Leiva, M., Ramos-Elias, P., Acevedo, A., Sukhin, V., Cloven, N., Pereira de Santana Gomes, A. J., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00317-9 · Cited by 410
Radiation Dose–Volume Effects of the Urinary Bladder
Viswanathan, A. N., Yorke, E. D., Marks, L. B., Eifel, P. J., & Shipley, W. U. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.090 · Cited by 404
Self-citationNCCN Guidelines® Insights: Cervical Cancer, Version 1.2024: Featured Updates to the NCCN Guidelines
Abu-Rustum, N. R., Yashar, C. M., Arend, R., Barber, E., Bradley, K., Brooks, R., Campos, S. M., Chino, J., Chon, H. S., Crispens, M. A., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.0062 · Cited by 384
Self-citationGill, B. S., Lin, J. F., Krivak, T. C., Sukumvanich, P., Laskey, R. A., Ross, M. S., Lesnock, J. L., & Beriwal, S. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.07.017 · Cited by 336
Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
Chino, J., Annunziata, C. M., Beriwal, S., Bradfield, L., Erickson, B. A., Fields, E. C., Fitch, K., Harkenrider, M. M., Holschneider, C. H., Kamrava, M., et al. (2020) · Practical Radiation Oncology · doi:10.1016/j.prro.2020.04.002 · Cited by 313
Positron Emission Tomography (PET) in Oncology
Gallamini, A., Zwarthoed, C., & Borra, A. (2014) · Cancers · doi:10.3390/cancers6041821 · Cited by 312
Rose, P. G., Ali, S., Watkins, E., Thigpen, J. T., Deppe, G., Clarke-Pearson, D. L., & Insalaco, S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4532 · Cited by 284
Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC) (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008285 · Cited by 275
Monk, B. J., Tewari, K. S., & Koh, W.-J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8324 · Cited by 261
Therapeutic hyperthermia: The old, the new, and the upcoming
Mallory, M., Gogineni, E., Jones, G. C., Greer, L., & Simone, C. B. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.003 · Cited by 258
SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway
Huang, C., Lu, H., Li, J., Xie, X., Fan, L., Wang, D., Tan, W., Wang, Y., Lin, Z., & Yao, T. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.005 · Cited by 51
Legge, F., Chiantera, V., Macchia, G., Fagotti, A., Fanfani, F., Ercoli, A., Gallotta, V., Morganti, A. G., Valentini, V., Scambia, G., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.04.035 · Cited by 43
Metadata
- Authors
- Eifel, P. J., Winter, K., Morris, M., Levenback, C., Grigsby, P. W., Cooper, J., Rotman, M., Gershenson, D., & Mutch, D. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-03-01
- Volume
- 22
- Issue
- 5
- Pages
- 872-880
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2097945491
- Cited by
- 1,018
- References
- 15
- FWCI
- 47.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.